HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mokenge Malafa Selected Research
Mokenge Malafa Research Topics
Disease
31
Neoplasms (Cancer)
12/2023 - 01/2006
14
Adenocarcinoma
12/2023 - 10/2007
14
Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 02/2011
7
Carcinogenesis
03/2018 - 01/2007
4
Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 01/2007
3
Neoplasms, Cystic, Mucinous, and Serous
01/2023 - 12/2016
3
Disease Progression
07/2021 - 02/2007
3
Stomach Neoplasms (Stomach Cancer)
01/2019 - 12/2011
3
Neoplasm Metastasis (Metastasis)
02/2007 - 01/2006
2
Melanoma (Melanoma, Malignant)
01/2023 - 01/2016
2
Adenoma (Adenomas)
07/2018 - 09/2007
2
Colonic Neoplasms (Colon Cancer)
07/2018 - 01/2007
2
Pancreatic Intraductal Neoplasms
09/2015 - 01/2015
2
Pancreatic Cyst
01/2015 - 01/2015
2
Breast Neoplasms (Breast Cancer)
04/2009 - 07/2006
2
Pathologic Complete Response
04/2009 - 07/2006
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2024
1
Abdominal Pain (Pain, Abdominal)
12/2023
1
Atrial Fibrillation
12/2023
1
Cholangitis
12/2023
1
Colitis
12/2023
1
Duodenal Obstruction
12/2023
1
Fever (Fevers)
12/2023
1
Infections
12/2023
1
Pneumonia (Pneumonitis)
12/2023
1
Respiratory Insufficiency (Respiratory Failure)
12/2023
1
Abdominal Abscess
12/2023
1
Sepsis (Septicemia)
12/2023
1
Acute Kidney Injury (Acute Renal Failure)
12/2023
1
Microsatellite Instability
01/2023
1
Surgical Wound Infection
11/2022
1
Margins of Excision
11/2022
1
Rectal Neoplasms (Rectal Cancer)
01/2022
1
Drug-Related Side Effects and Adverse Reactions
07/2021
1
End Stage Liver Disease
01/2018
1
Cholangiocarcinoma
01/2018
1
Rupture
01/2017
1
Mucocele
01/2017
1
Pseudomyxoma Peritonei
01/2017
Drug/Important Bio-Agent (IBA)
12
Biomarkers (Surrogate Marker)
IBA
12/2023 - 02/2007
5
MicroRNAs (MicroRNA)
IBA
12/2016 - 02/2011
4
Proteins (Proteins, Gene)
FDA Link
07/2018 - 01/2015
3
RNA (Ribonucleic Acid)
IBA
12/2023 - 01/2021
3
Antigens
IBA
01/2018 - 01/2016
3
triciribine
IBA
09/2015 - 09/2007
2
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 01/2021
2
Capecitabine (Xeloda)
FDA Link
01/2022 - 08/2011
2
Hormones (Hormone)
IBA
01/2020 - 01/2006
2
Gemcitabine
FDA Link
09/2015 - 08/2011
2
Dihydrotachysterol (AT 10)
IBA
07/2014 - 01/2014
2
Cytotoxins (Cytolysins)
IBA
10/2013 - 04/2009
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2009 - 07/2006
2
Doxorubicin (Adriamycin)
FDA Link
Generic
04/2009 - 07/2006
2
tipifarnib (R115777)
IBA
04/2009 - 07/2006
2
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
10/2007 - 09/2007
2
API 2
IBA
10/2007 - 09/2007
1
Immunologic Factors (Immunomodulators)
IBA
05/2024
1
Nivolumab
IBA
12/2023
1
regorafenib
IBA
12/2023
1
avasopasem manganese
IBA
12/2023
1
Alkaline Phosphatase
IBA
12/2023
1
Lipase (Acid Lipase)
FDA Link
12/2023
1
Lactic Acid (Lactate)
FDA Link
Generic
12/2023
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2022
1
First Generation Cephalosporins
IBA
11/2022
1
Second Generation Cephalosporins
IBA
11/2022
1
lenvatinib
IBA
01/2022
1
Genie
IBA
01/2021
1
4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamide
IBA
01/2021
1
Antipsychotic Agents (Antipsychotics)
IBA
01/2020
1
Tocopherols (Tocopherol)
IBA
01/2020
1
Vitamin E
FDA Link
Generic
01/2020
1
Penfluridol (Semap)
IBA
01/2020
1
Prolactin
IBA
01/2020
1
Tocotrienols
IBA
01/2020
1
Prolactin Receptors (Prolactin Receptor)
IBA
01/2020
1
Bilirubin
IBA
01/2018
1
Yttrium-90
IBA
01/2018
1
Albumins
IBA
01/2018
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2018
1
Mucins
IBA
01/2017
Therapy/Procedure
11
Therapeutics
05/2024 - 01/2006
8
Drug Therapy (Chemotherapy)
12/2023 - 04/2009
5
Radiotherapy
01/2023 - 01/2017
2
Neoadjuvant Therapy
01/2023 - 01/2022
2
Immunotherapy
01/2023 - 11/2020
2
Pancreaticoduodenectomy
11/2022 - 01/2022
2
Laparotomy
01/2017 - 11/2015
2
Complementary Therapies (Alternative Medicine)
02/2013 - 01/2006
2
Chemoprevention
02/2013 - 01/2007
2
Cytoreduction Surgical Procedures
02/2007 - 01/2006
1
Stents
11/2022
1
Adjuvant Chemoradiotherapy
01/2022
1
Chemoradiotherapy
01/2022
1
Adjuvant Chemotherapy
01/2022
1
Molecular Targeted Therapy
01/2021
1
Precision Medicine
01/2021
1
Injections
01/2020
1
Microspheres (Microsphere)
01/2018
1
Appendectomy
01/2017